232 related articles for article (PubMed ID: 12036449)
1. Hepatocyte nuclear factor (HNF)-4alpha induces expression of endothelial Fas ligand (FasL) to prevent cancer cell transmigration: a novel defense mechanism of endothelium against cancer metastasis.
Osanai M; Chiba H; Kojima T; Fujibe M; Kuwahara K; Kimura H; Satoh M; Sawada N
Jpn J Cancer Res; 2002 May; 93(5):532-41. PubMed ID: 12036449
[TBL] [Abstract][Full Text] [Related]
2. Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression.
Hatzis P; Talianidis I
Mol Cell Biol; 2001 Nov; 21(21):7320-30. PubMed ID: 11585914
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.
Yoo YG; Lee MO
J Biol Chem; 2004 Aug; 279(35):36242-9. PubMed ID: 15173177
[TBL] [Abstract][Full Text] [Related]
4. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
[TBL] [Abstract][Full Text] [Related]
5. CC531s colon carcinoma cells induce apoptosis in rat hepatic endothelial cells by the Fas/FasL-mediated pathway.
Vekemans K; Timmers M; Vermijlen D; De Zanger R; Wisse E; Braet F
Liver Int; 2003 Aug; 23(4):283-93. PubMed ID: 12895269
[TBL] [Abstract][Full Text] [Related]
6. Activation of p21CIP1/WAF1 gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha.
Chiba H; Itoh T; Satohisa S; Sakai N; Noguchi H; Osanai M; Kojima T; Sawada N
Exp Cell Res; 2005 Jan; 302(1):11-21. PubMed ID: 15541721
[TBL] [Abstract][Full Text] [Related]
7. Analysis of gene expression profile induced by hepatocyte nuclear factor 4alpha in hepatoma cells using an oligonucleotide microarray.
Naiki T; Nagaki M; Shidoji Y; Kojima H; Imose M; Kato T; Ohishi N; Yagi K; Moriwaki H
J Biol Chem; 2002 Apr; 277(16):14011-9. PubMed ID: 11834723
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of drug-induced Fas ligand transcription and apoptosis by Bcl-XL.
Biswas RS; Cha HJ; Hardwick JM; Srivastava RK
Mol Cell Biochem; 2001 Sep; 225(1-):7-20. PubMed ID: 11716366
[TBL] [Abstract][Full Text] [Related]
9. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
10. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappaB mediates Kupffer cell apoptosis through transcriptional activation of Fas/FasL.
Peng Y; Gallagher SF; Haines K; Baksh K; Murr MM
J Surg Res; 2006 Jan; 130(1):58-65. PubMed ID: 16154149
[TBL] [Abstract][Full Text] [Related]
12. The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas.
Gutierrez LS; Eliza M; Niven-Fairchild T; Naftolin F; Mor G
Breast Cancer Res Treat; 1999 Apr; 54(3):245-53. PubMed ID: 10445423
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte nuclear factor (HNF)-4alpha triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells.
Chiba H; Gotoh T; Kojima T; Satohisa S; Kikuchi K; Osanai M; Sawada N
Exp Cell Res; 2003 Jun; 286(2):288-97. PubMed ID: 12749857
[TBL] [Abstract][Full Text] [Related]
14. Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues.
Xerri L; Devilard E; Hassoun J; Mawas C; Birg F
Mol Pathol; 1997 Apr; 50(2):87-91. PubMed ID: 9231156
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
Delgado M; Ganea D
J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
[TBL] [Abstract][Full Text] [Related]
16. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
[TBL] [Abstract][Full Text] [Related]
17. Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells.
Asanuma K; Tsuji N; Endoh T; Yagihashi A; Watanabe N
J Immunol; 2004 Mar; 172(6):3922-9. PubMed ID: 15004200
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis.
Jayanthi S; Deng X; Ladenheim B; McCoy MT; Cluster A; Cai NS; Cadet JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):868-73. PubMed ID: 15644446
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone receptor interacting protein 3 (trip3) is a novel coactivator of hepatocyte nuclear factor-4alpha.
Iwahashi H; Yamagata K; Yoshiuchi I; Terasaki J; Yang Q; Fukui K; Ihara A; Zhu Q; Asakura T; Cao Y; Imagawa A; Namba M; Hanafusa T; Miyagawa J; Matsuzawa Y
Diabetes; 2002 Apr; 51(4):910-4. PubMed ID: 11916906
[TBL] [Abstract][Full Text] [Related]
20. High Fas ligand expression on lymphocytes in lesions of ulcerative colitis.
Ueyama H; Kiyohara T; Sawada N; Isozaki K; Kitamura S; Kondo S; Miyagawa J; Kanayama S; Shinomura Y; Ishikawa H; Ohtani T; Nezu R; Nagata S; Matsuzawa Y
Gut; 1998 Jul; 43(1):48-55. PubMed ID: 9771405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
